Network Services

Clinical Network Services (CNS) is a leading international contract research organization (CRO) that specializes in providing integrated product development services for small-to-medium-sized biotechnology companies. Headquartered in Australia, the company focuses on the planning, implementation, and delivery of Phase 1 and Phase 2 clinical trials, leveraging regional regulatory advantages to accelerate drug development timelines. CNS is particularly known for its BioDesk subunit, which offers expert consulting in regulatory affairs, CMC, and toxicology to help clients navigate the transition from discovery to the clinic. In 2018, the company was acquired by Novotech, further expanding its reach and capabilities across the Asia-Pacific region and beyond. CNS continues to operate as a specialized service provider within the Novotech group, supporting a wide range of therapeutic modalities including small molecules and advanced biologics.